Pharmacogenomics · 2016 · 35 citations · 22 references
Life SciencesMolecular BiologyOncologyApoptosisGene ExpressionMolecular OncologyApoptosis In CancerApoptosis RegulationApoptosis ResistanceMicrorna BiologyMicrorna-mediated RegulationOvarian CancerAnticancer ChemotherapyAnticancer Drug ResistanceApoptosis-regulating MicrornasCellular ProliferationLuciferase Reporter AssaysLuciferase ReportersMicrorna In CancerMicrorna Regulation In Cancer
AIMS: XIAP is upregulated in chemoresistant epithelial ovarian cancer (EOC). However, the molecular mechanism of this dysregulation remains unclear. MATERIALS & METHODS: The regulation of XIAP by miR-509-3p was investigated by luciferase reporter assay, real-time PCR and immunobloting, and the roles of miR-509-3p in cellular proliferation and apoptosis were accessed through MTT and DAPI assays. RESULTS: miR-509-3p, a downregulated miRNA in chemoresistant EOC, can directly target the XIAP via its 3'UTR. Overexpression of miR-509-3p can not only downregulate the expression of XIAP in ovarian cancer cells but also inhibit the proliferation of EOC cells and increase their sensitivity to cisplatin-induced apoptosis. CONCLUSIONS: Our data suggest that restoring certain dysregulated miRNAs to their normal levels could increase the therapeutic effects of anticancer drugs.
22
MicroRNA expression profiles classify human cancers
Jun Lü, Gad Getz, Eric A. Miska et al. · Nature · 2005 · 9.6K citations
Bino John, Anton J. Enright, Alexei A. Aravin et al. · PLoS Biology · 2004 · 3.9K citations · Full text
MicroRNA Signatures in Human Ovarian Cancer
Marilena V. Iorio, Rosa Visone, Gianpiero Di Leva et al. · Cancer Research · 2007 · 1.4K citations · Full text